A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns

Simply Wall St.

Mar 13

Astrana Health (ASTH) has been drawing fresh attention after its recent rebrand from Apollo Medical Holdings, shifting its identity while continuing to focus on healthcare management and coordination ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2619915233"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2619915233\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2619915233?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-03-13 10:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619915233","market":"sg","top_or_hot":-1,"title":"A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns","media":"Simply Wall St.","content":"<div>\n<p>Astrana Health (ASTH) has been drawing fresh attention after its recent rebrand from Apollo Medical Holdings, shifting its identity while continuing to focus on healthcare management and coordination ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/a-look-at-astrana-health-asth-valuation-after-rebrand-and-mi\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-13 10:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/a-look-at-astrana-health-asth-valuation-after-rebrand-and-mi><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Astrana Health (ASTH) has been drawing fresh attention after its recent rebrand from Apollo Medical Holdings, shifting its identity while continuing to focus on healthcare management and coordination ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/a-look-at-astrana-health-asth-valuation-after-rebrand-and-mi\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ASTH","symbol_name":"Astrana Health","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/a-look-at-astrana-health-asth-valuation-after-rebrand-and-mi","article_id":"2619915233","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/a-look-at-astrana-health-asth-valuation-after-rebrand-and-mi","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619915233","pubTimestamp":1773369050,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Astrana Health (ASTH) has been drawing fresh attention after its recent rebrand from Apollo Medical Holdings, shifting its identity while continuing to focus on healthcare management and coordination across Medicare, Medicaid and commercially insured patients.\nSee our latest analysis for Astrana Health.\nThe recent rebrand comes against a mixed backdrop, with a 30 day share price return of 20.65% contrasting with a 1 year total shareholder return decline of 20.36%. This suggests shorter term...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"ASTH":"Astrana Health","BK4196":"保健护理服务"},"translate_title":"看看Astrana Health(ASTH)品牌重塑和混合股东回报后的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASTH":1.5},"content_text":"Astrana Health (ASTH) has been drawing fresh attention after its recent rebrand from Apollo Medical Holdings, shifting its identity while continuing to focus on healthcare management and coordination across Medicare, Medicaid and commercially insured patients. See our latest analysis for Astrana Health. The recent rebrand comes against a mixed backdrop, with a 30 day share price return of 20.65% contrasting with a 1 year total shareholder return decline of 20.36%. This suggests shorter term momentum while longer term holders have seen weaker results. If this kind of rebound catches your eye, it may be worth scanning other healthcare names using our 34 healthcare AI stocks as a starting list of ideas. With Astrana posting annual revenue and net income growth alongside a discount of about 46% to the average analyst price target and an indicated intrinsic discount of roughly 77%, you have to ask: is this a mispriced healthcare operator, or is the market already baking in all the future gains? AdvertisementMost Popular Narrative: 34.8% Undervalued With Astrana's fair value estimate at about $35.67 versus the last close at $23.25, the most widely followed narrative sees a sizeable valuation gap that hinges on execution over the next few years.  Recent research updates show analysts reassessing Astrana Health's potential as they wait for clearer evidence on full risk contract conversions and Medicare Advantage performance in 2026. Price targets have been adjusted, but the core debate centers on execution timing and how much value investors should attach to longer term opportunities.  Read the complete narrative. Curious what kind of revenue growth, margin uplift and future earnings multiple have to come together to support that higher fair value? The full narrative lays out a detailed roadmap built around value based contracts, Medicare Advantage assumptions and how much investors might eventually pay for those projected earnings. Result: Fair Value of $35.67 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there is still meaningful risk that heavy reliance on Medicare and Medicaid reimbursement, along with execution hurdles around full risk contract conversions, could undercut that upside story. Find out about the key risks to this Astrana Health narrative. Another Angle On The Valuation The first story paints Astrana as undervalued, with the share price at $23.25 compared with a fair value estimate of $35.67 and even a DCF based future cash flow value of $102.64. Yet on a simple P/E of 50.5x versus a fair ratio of 35.6x, the stock screens as expensive. Which signal do you respect more? See what the numbers say about this price — find out in our valuation breakdown. NasdaqCM:ASTH P/E Ratio as at Mar 2026Next Steps If the mix of upside and concern feels hard to weigh, check the numbers for yourself and move quickly to form your own stance with 2 key rewards and 3 important warning signs. Looking for more investment ideas? If Astrana has sparked your interest, do not stop here. Use focused stock lists to spot other opportunities that could suit your style before the crowd catches on.  Target reliable income by scanning companies that show up in our 15 dividend fortresses and see which payouts might fit a long term portfolio. Hunt for value by reviewing our 48 high quality undervalued stocks, a list built to highlight companies trading at prices that may not fully reflect their fundamentals. Prioritize resilience by checking the 68 resilient stocks with low risk scores and focus on businesses with risk profiles that could better match a more cautious approach.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}